Cleveland BioLabs

$3.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (+3.32%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell CBLI and other stocks, options, and ETFs commission-free!

About CBLI

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. The listed name for CBLI is Cleveland BioLabs, Inc. Common Stock.

CEO
Christopher Zosh
Employees
12
Headquarters
Buffalo, New York
Founded
2003
Market Cap
41.48M
Price-Earnings Ratio
Dividend Yield
Average Volume
116.66K
High Today
$3.18
Low Today
$2.95
Open Price
$3.00
Volume
92.01K
52 Week High
$5.43
52 Week Low
$0.515

Collections

CBLI Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.06 per share

You May Also Like